TY  - GEN
AU  - Viúdez,A
AU  - Carmona-Bayonas,A
AU  - Gallego,J
AU  - Lacalle,A
AU  - Hernández,R
AU  - Cano,J M
AU  - Macías,I
AU  - Custodio,A
AU  - Martínez de Castro,E
AU  - Sánchez,A
AU  - Iglesia,L
AU  - Reguera,P
AU  - Visa,L
AU  - Azkarate,A
AU  - Sánchez-Cánovas,M
AU  - Mangas,M
AU  - Limón,M L
AU  - Martínez-Torrón,A
AU  - Asensio,E
AU  - Ramchandani,A
AU  - Martín-Carnicero,A
AU  - Hurtado,A
AU  - Cerdà,P
AU  - Garrido,M
AU  - Sánchez-Bayonas,R
AU  - Serrano,R
AU  - Jiménez-Fonseca,P
TI  - Optimal duration of first-line chemotherapy for advanced gastric cancer: data from the AGAMENON registry
SN  - 1699-3055
PY  - 2020///1223
KW  - Adult
KW  - Aged
KW  - Aged, 80 and over
KW  - Antineoplastic Combined Chemotherapy Protocols
KW  - therapeutic use
KW  - Clinical Decision-Making
KW  - Female
KW  - Humans
KW  - Maintenance Chemotherapy
KW  - Male
KW  - Middle Aged
KW  - Platinum
KW  - administration & dosage
KW  - Progression-Free Survival
KW  - Pyrimidines
KW  - Registries
KW  - Stomach Neoplasms
KW  - drug therapy
KW  - Survival Rate
KW  - Time Factors
KW  - Young Adult
N1  - Publication Type: Journal Article; Multicenter Study
UR  - https://doi.org/10.1007/s12094-019-02183-y
ER  -